Idexx Laboratories (IDXX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 214,054 | 679,089 | 506,882 | 325,944 | 193,965 |
| Depreciation Amortization | 28,331 | 111,900 | 83,180 | 54,633 | 26,511 |
| Income taxes - deferred | -3,757 | -35,065 | -36,890 | -23,517 | -5,028 |
| Accounts receivable | -44,133 | -41,398 | -35,061 | -53,794 | -37,531 |
| Accounts payable and accrued liabilities | 3,327 | 3,467 | -3,930 | -6,735 | -4,016 |
| Other Working Capital | -70,609 | -273,530 | -229,597 | -206,951 | -114,242 |
| Other Operating Activity | 56,699 | 98,521 | 84,972 | 90,976 | 55,047 |
| Operating Cash Flow | $183,912 | $542,984 | $369,556 | $180,556 | $114,706 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | -25,000 | -25,000 | -25,000 | N/A |
| PPE Investments | -39,511 | -148,838 | -99,609 | -61,924 | -31,838 |
| Net Acquisitions | N/A | -11,512 | -11,512 | N/A | N/A |
| Purchase Sale Intangibles | N/A | -10,000 | -10,000 | -10,000 | -10,000 |
| Other Investing Activity | 0 | -10,000 | -10,000 | -10,000 | -10,000 |
| Investing Cash Flow | $-39,511 | $-195,350 | $-146,121 | $-96,924 | $-41,838 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | 559,500 | 537,500 | 326,500 |
| Debt Repayment | N/A | -75,000 | -75,000 | -75,000 | -75,000 |
| Common Stock Issued | 12,796 | 35,747 | N/A | N/A | 11,653 |
| Common Stock Repurchased | -9,597 | -830,317 | -756,243 | -583,450 | -276,633 |
| Other Financing Activity | -149,280 | 498,634 | 17,527 | 15,563 | 0 |
| Financing Cash Flow | $-146,081 | $-370,936 | $-254,216 | $-105,387 | $-13,480 |
| Exchange Rate Effect | 501 | -8,606 | -14,497 | -8,337 | 776 |
| Beginning Cash Position | 112,546 | 144,454 | 144,454 | 144,454 | 144,454 |
| End Cash Position | 111,367 | 112,546 | 99,176 | 114,362 | 204,618 |
| Net Cash Flow | $-1,179 | $-31,908 | $-45,278 | $-30,092 | $60,164 |
| Free Cash Flow | |||||
| Operating Cash Flow | 183,912 | 542,984 | 369,556 | 180,556 | 114,706 |
| Capital Expenditure | -39,511 | -148,838 | -99,609 | -61,924 | -31,838 |
| Free Cash Flow | 144,401 | 394,146 | 269,947 | 118,632 | 82,868 |